Glucose Health, Inc. research brief
CIK 1420108
Generated Nov. 4, 2026, 3:06 p.m. from up to 100 stored Form D disclosures. A CIK identifies a filer, not a single offering.
Current stored business address: BENTONVILLE AR. Reported legal jurisdiction: DELAWARE. These do not establish investor residence or where funds were deployed.
- Oct. 19, 2026 · D · 0001420108-26-000007 · Source evidence
Reported offering amount: 60000 USD. Reported amount sold: 60000 USD.
- Oct. 7, 2026 · D · 0001420108-26-000006 · Source evidence
Reported offering amount: 172500 USD. Reported amount sold: 172500 USD.
- Oct. 6, 2026 · D · 0001420108-26-000005 · Source evidence
Reported offering amount: 30000 USD. Reported amount sold: 30000 USD.
- Oct. 6, 2026 · D · 0001420108-26-000004 · Source evidence
Reported offering amount: 12000 USD. Reported amount sold: 12000 USD.
- Sept. 10, 2026 · D · 0001420108-26-000003 · Source evidence
Reported offering amount: 30000 USD. Reported amount sold: 10000 USD.
- July 7, 2026 · D · 0001420108-26-000002 · Source evidence
Reported offering amount: 120000 USD. Reported amount sold: 60000 USD.
- Feb. 4, 2026 · D · 0001420108-26-000001 · Source evidence
Reported offering amount: 100000 USD. Reported amount sold: 100000 USD.
- Dec. 5, 2025 · D · 0001420108-25-000002 · Source evidence
Reported offering amount: 20000 USD. Reported amount sold: 20000 USD.
Reviewed offering links
- No independently reviewed offering relationship is recorded. Adjacent filings are not assumed to belong to one offering.
Citation: Form D Explorer, “Glucose Health, Inc. research brief,” CIK 1420108, retrieved Nov. 4, 2026, 3:06 p.m.. Cite the specific accessions used. No amounts have been summed.